NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-180-2005-0-US-04 Scytovirin Domain 1 Related Polypeptides US ORD 11/914,833 8067530 Issued PDF
NIDCR E-038-2013-0-US-03 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH US National Stage 11/941,723 8299046 Issued PDF
NIDCR E-038-2013-0-PCT-02 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH PCT PCT PCT/US2007/085006 Expired
NHLBI E-249-2006-2-EP-02 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device EP National Stage 07861997.0 Issued
NHLBI E-249-2006-2-GB-08 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device GB EP 07861997.0 Issued
NHLBI E-249-2006-2-CH-05 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device CH EP 07861997.0 Issued
NHLBI E-249-2006-2-FR-07 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device FR EP 07861997.0 Issued
NHLBI E-249-2006-2-DE-06 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device DE EP 07861997.0 Issued
NHLBI E-249-2006-2-PCT-01 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device PCT PCT COMB PCT/US2007/023876 Expired
NIA E-222-2000-0-US-07 Tetrahydrobenzothiazole Analogues as Neuroprotective Agents US CON 11/939,515 Abandoned
NIAID E-051-2005-0-US-03 Identification of A Fusion/Entry Receptor For Human Herpesvirus-8 US National Stage 11/920,376 Abandoned
NCI E-248-2005-0-US-01 NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYURETHANE AND POLYUREA POLYMERS, AND COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF US 60/987,537 Abandoned
NIAID E-003-2005-0-DE-05 Methods of Treating and Preventing Inflammatory Bowel Disease Involving IL-13 and NKT Cells DE EP 06750435.7 Issued
NIAID E-003-2005-0-FR-07 Methods of Treating and Preventing Inflammatory Bowel Disease Involving IL-13 and NKT Cells FR EP 06750435.7 Issued
NIAID E-003-2005-0-ES-06 Methods of Treating and Preventing Inflammatory Bowel Disease Involving IL-13 and NKT Cells ES EP 06750435.7 Issued
NIAID E-003-2005-0-GB-08 Methods of Treating and Preventing Inflammatory Bowel Disease Involving IL-13 and NKT Cells GB EP 06750435.7 Issued
NIAID E-003-2005-0-IT-09 Methods of Treating and Preventing Inflammatory Bowel Disease Involving IL-13 and NKT Cells IT EP 06750435.7 Issued
NCI E-033-2008-0-US-01 Diagnostic And Therapeutic Applications Of A P53 Isoform In Regenerative Medicine, Aging And Cancer US 60/987,340 Abandoned
NIAID E-029-2007-0-PCT-02 A Varicella-zoster Virus Mutant That Is Markedly Impaired For Latent Infection PCT PCT PCT/US2007/084331 Expired
NIAID E-108-2005-0-US-03 Compositions And Methods For The Treatment Of Inflammatory Bowel Disease (IBD) Utilizing NF-KB Decoy Polynucleotides US National Stage 11/920,214 Abandoned
NCI E-015-2005-0-US-06 ANTI-MESOTHELIN ANTIBODIES USEFUL FOR IMMUNOLOGICAL ASSAYS US National Stage 11/920,222 Abandoned
NCI E-012-2008-0-US-01 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV US 61/002,711 Abandoned
NCI E-208-2006-0-PCT-03 INFLUENZA VIRUS NUCLEIC ACID MICROARRAY AND METHOD OF USE PCT PCT PCT/US2007/023448 Expired
NCI E-208-2006-0-US-02 INFLUENZA VIRUS NUCLEIC ACID MICROARRAY AND METHOD OF USE US ORD 11/936,530 Abandoned
NCI E-316-2007-0-US-01 Novel Natural Product Inhibitors Of ABCG2 From The Developmental Therapeutics Program Compound Collection US 60/986,155 Abandoned
NHLBI E-257-2005-0-US-04 Wide-Area Fluorescence Detection System For Multi-Photon Microscopy US CON 11/979,600 7667210 Issued PDF
NCI E-226-2006-0-PCT-02 METHOD OF PREPARING MACROMOLECULAR CONTRAST AGENTS AND USES THEREOF PCT PCT PCT/US2007/083734 Expired
NCI E-256-2006-0-PCT-02 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs PCT PCT PCT/US2007/083772 Expired
NCI E-256-2006-0-EP-06 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs EP National Stage 07868671.4 Abandoned
NCI E-256-2006-0-IN-07 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs IN National Stage 2947/DELNP/2009 Abandoned
NCI E-256-2006-0-CA-04 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs CA National Stage 2668638 Abandoned
NCI E-256-2006-0-AU-03 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs AU National Stage 2007316416 Abandoned
NCI E-139-2007-0-US-06 Methods And Compositions For Detecting Immune Responses US ORD 11/913,583 8703484 Abandoned PDF
NCI E-328-2007-0-US-01 Identification Of Persons Likely To Benefit From Statin Mediated Colon Cancer Prevention By Pharmacogenetics US 60/985,587 Abandoned
NICHD E-273-2007-0-US-01 METHODS AND APPARATUSES FOR ESTIMATING THE ELLIPTICAL CONE OF UNCERTAINTY US 60/996,169 Abandoned
NHGRI E-009-2007-0-PCT-02 COMPOSITIONS AND METHODS FOR PREDICTING BODY SIZE IN DOGS PCT PCT PCT/US2007/083496 Expired
NHLBI E-099-2008-0-US-01 Tandem L2 Fusion Vaccines For Prevention Of Human Papillomavirus Infection US 61/001,630 Abandoned
NCI E-050-2007-2-AU-02 MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma AU National Stage 2007314212 Abandoned
NCI E-050-2007-2-CH-10 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) CH EP 07867402.5 Abandoned
NCI E-050-2007-2-IT-13 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) IT EP 07867402.5 Abandoned
NCI E-050-2007-2-FR-11 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) FR EP 07867402.5 Abandoned
NCI E-050-2007-2-EP-04 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) EP National Stage 07867402.5 Abandoned
NCI E-050-2007-2-GB-12 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a) GB EP 07867402.5 Abandoned
NICHD E-043-1999-0-US-08 Utergolobin in The Treatment of IgA Meditated Nephropathy US CON 11/934,050 8084415 Abandoned PDF
NCI E-050-2007-2-PCT-01 Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling PCT PCT COMB PCT/US2007/023660 Expired
NCI E-050-2007-2-CA-03 Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling CA National Stage 2667617 Abandoned
NCI E-021-2001-0-US-10 Chromosome 3p21.3 Genes Are Tumor Suppressors US CON 11/932,724 7977468 Expired PDF
NCI E-057-1994-2-US-10 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/932,255 7803614 Expired PDF
NCI E-315-2003-0-US-03 SH2 Domain Binding Inhibitors US ORD 11/932,424 7767645 Abandoned PDF
NCI E-057-1994-2-US-08 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/932,826 7763586 Expired PDF